W. Grellner et B. Madea, IMMUNOHISTOCHEMICAL CHARACTERIZATION OF ALVEOLAR MACROPHAGES AND PULMONARY GIANT-CELLS IN FATAL ASPHYXIA, Forensic science international, 79(3), 1996, pp. 205-213
It is in dispute whether the occurrence of numerous alveolar macrophag
es and in particular pulmonary giant cells in cases of fatal asphyxia
is associated with agonal activation and proliferation. The nature of
these alveolar cells was investigated in selected fatalities with prot
racted final oxygen lack using immunohistochemistry (APAAP method) and
a semi-quantitative graduation. The study included opiate-involved de
aths (n = 22), fatal strangulations (n = 10) and a control group of su
dden cardiovascular deaths (n = 10). Positive immunohistochemical reac
tions were observed with the monoclonal antibodies PG-M1 (general mark
er of macrophages, detection of nearly 100% of pulmonary macrophages a
nd giant cells in all subgroups) and 25 F 9 (late stage inflammation m
arker, detection of pulmonary macrophages/giant cells in 70%/50% of op
iate-involved fatalities, 70%/20% of strangulations and 40%/30% of con
trol cases). The antibodies LN-4 (macrophages), 27 E 10 (early stage i
nflammation marker), AMH 152 (activated macrophages) and MIB 1 (prolif
eration marker) did not react with these cell populations. Conclusions
: pulmonary giant cells and numerous alveolar macrophages are not rest
ricted to asphyxia. Their appearance is not of pathognomonic value for
this diagnosis. Both cell types seem to be of heterogeneous nature (d
ifferent functional state) as only one marker was expressed by all cel
ls. The results do not suggest prefinal immigration, mobilization or p
roliferation of alveolar cells, but rather point to a longer pre-exist
ence of macrophages and giant cells in pulmonary tissue (25 F 9 as lat
e stage inflammation marker positive).